Cardiovascular Outcomes With SGLT2 Inhibitors in T2D Compared

The comparative effectiveness of several SGLT2 inhibitors in participants with type 2 diabetes and cardiovascular risk factors.

Related Keywords

United States ,American , ,American Heart Association Scientific Sessions ,Cardiology Advisor ,Heart Association Scientific Sessions ,